申请人:Laurus Labs Private Limited
公开号:US20160017002A1
公开(公告)日:2016-01-21
The present invention provides processes for preparation of eptifibatide that involve coupling of amino acids in a (2+5), (4+3) and (3+4) sequence method. The invention further provides products produced by the described processes, novel compounds that can be used as synthetic intermediates for the preparation of eptifibatide.
本发明提供了制备依普替肽的方法,包括使用(2+5)、(4+3)和(3+4)序列方法耦合氨基酸。本发明还提供了由所述方法制备的产品,以及可用作依普替肽制备的合成中间体的新化合物。